Skin Antiseptic Products Market Size, Growth, Trends | Report 2022-2030
The global skin antiseptic products market was surpassed at USD 252.3 million in 2021 and is expected to hit around USD 478.5 million by 2030, growing at a CAGR of 8.2% from 2022 to 2030.
Rising incidences of Hospital-Acquired Infections (HAIs) and increasing usage of surgical units and endoscope reprocesses are the key driving factors for the market. The rising number of surgeries being performed is also expected to drive the market during the forecast period. According to the Agency for Healthcare Research and Quality (AHRQ), 17.2 million hospital visits included surgical procedures in the U.S. in 2014.
Demand for alcohol antiseptics for pre-injection and pre-operative skin preparations is increasing significantly. In addition, alcohol antiseptics are being used as a base along with various formulations, such as iodine and chlorhexidine. Exceptional properties of alcohol-based antiseptics for surgical purposes are driving the market. Growing awareness regarding the benefits of skin antiseptic products and increasing R&D funding are creating opportunities for market entrants. Moreover, various programs being conducted by manufacturers and governments to boost the awareness about the importance of using skin antiseptic products are also expected to contribute significantly to the skin antiseptic product market growth.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 252.3 million |
| Revenue Forecast by 2030 | USD 478.5 million |
| Growth rate from 2022 to 2030 | CAGR of 8.2% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Formulation, type, application |
| Companies Covered | 3M; Ecolab; BD; Sage Products LLC; B.Braun Melsungen AG; Schulke & Mayr GmbH; Cardinal Health; Smith & Nephew; Avrio Health; Microgen. |
Formulation Insights
The alcohols segment dominated the skin antiseptic products market in 2021, owing to increasing usage for pre-injection and pre-operative skin preparation. Furthermore, the growing demand for alcohol base to be used in combination with other formulations, such as iodine and chlorhexidine, is fueling the segment growth. In addition, alcohol skin antiseptic products comprise antiseptic agents, such as isopropyl or ethyl. These are effective against numerous microbes.
The octenidine skin antiseptic products market is anticipated to witness the fastest growth of 7.5% during the forecast period. It is an internal substitute for chlorhexidine and iodine skin antiseptic products. Moreover, in countries such as the U.S., the FDA has restricted the use of chlorhexidine & iodine. This may help in the growth of the market for alternatives such as octenidine.
Type Insights
Based on the type of skin antiseptic products, solutions were the highest revenue-generating segment with a market share of 48.44% in 2021. This can be accredited to the high prevalence of hospital-acquired infections & SSIs and the easy availability of numerous solutions in the market. Moreover, growing awareness and increasing applications of antiseptic solutions in pre-operation and pre-injection skin preparation are impelling the market. Antiseptic solutions significantly reduce the contamination risk and transmission of infections.
In addition, rising cases of hospital-acquired infections have led to a growth in the usage of antiseptics for surgeries. For instance, as per NCBI, approximately, 1.7 million hospitalizations initiate hospital-acquired infections annually. Similarly, according to an article by European Center for Disease Prevention and Control in 2018, around 8.9 million HAIs were estimated to arise every year in European long-term care facilities and hospitals. Therefore, due to the above-mentioned factors, the solution segment is predicted to witness significant growth throughout the forecast period.
However, the wipes segment is anticipated to witness the fastest CAGR of 7.2% during the forecast period. Wipes are easy to use, which helps in film and tape adhesion. Furthermore, wipes are extremely effective for wound application, as they completely clean the wound area, leaving behind no residue.
Application insights
The injection segment dominated the skin antiseptic products market in 2021 with a market share of 90.17% and is anticipated to witness the fastest growth throughout the forecast period. The growth of the segment is attributable to the increasing use of joint injections for extracting fluid from swollen joints for injecting medicines. The growing geriatric population and individuals suffering from joint injuries and sports-related wounds respectively are the primary users of these injections. Furthermore, joint injections carrying zero side effects are gaining popularity among patients, which is again expected to expand the market considerably during the forecast period.
The surgeries segment is anticipated to witness a significant CAGR of 6.5% during the forecast period. The growth rate can be credited to the globally rising number of surgical cases. For instance, as per the Aesthetics Society, 252,022 breast augmentations, 296,601 liposuctions, and 163,073 abdominoplasty surgeries were recorded in the year 2020, thus helping the segment growth.
Regional Insights
North America dominated the global skin antiseptic products market in 2021 and is expected to lead the market throughout the forecast period. The rising number of surgeries in this region is one of the major drivers positively impacting the market growth. Preoperative skin preparation is one of the essential steps adopted by surgeons before surgical treatments. Thus, the demand for skin-antiseptic products is anticipated to rise with the increasing rate of surgical actions.
Asia-Pacific skin antiseptic products market is expected to witness the fastest growth rate of 7.4% during the forecast period. Increasing healthcare expenditure by the public and private sectors is one of the major driving factors for the market. Such a scenario is anticipated to encourage several major and local players to enter in the market, due to which growth is expected.
Key Players
3M
Ecolab
BD
Sage Products LLC
B.Braun
Melsungen AG
Johnson & Johnson
Schulke & Mayr GmbH
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Skin Antiseptic Products Market
5.1. COVID-19 Landscape: Skin Antiseptic Products Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Skin Antiseptic Products Market, By Formulation
8.1. Skin Antiseptic Products Market, by Formulation, 2022-2030
8.1.1 Alcohols
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Chlorhexidine
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Iodine
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Octenidine
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Skin Antiseptic Products Market, By Type
9.1. Skin Antiseptic Products Market, by Type, 2022-2030
9.1.1. Solutions
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Swab Sticks
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Wipes
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Skin Antiseptic Products Market, By Application
10.1. Skin Antiseptic Products Market, by Application, 2022-2030
10.1.1. Surgeries
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Injections
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Skin Antiseptic Products Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.1.2. Market Revenue and Forecast, by Type (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.2.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.3.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Formulation (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
Chapter 12. Company Profiles
12.1. 3M
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Ecolab
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. BD
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Sage Products LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. B.Braun
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Melsungen AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Johnson & Johnson
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Schulke & Mayr GmbH
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers